Dear Somebody,
Thousands of people in Cheshire and Merseyside are being invited to take part in pioneering Liverpool-led research that could shape the future of lung cancer screening. They are investigating if a simple blood test can identify people at risk of lung cancer so that scans can be targeted at them to spot any disease in its early stages.
The APPLIED-LUNG: Transforming Lung Cancer Screening study is co-funded by the National Institute for Health and Care Research (NIHR) and Oxford Cancer Analytics (OXcan), including a £1.68 million NIHR i4i Product Development Award. So far, the study has already recruited around 1,500 participants since launching earlier this year and aims to involve up to 11,000 people attending routine low-dose CT scans as part of the Cheshire and Merseyside NHS Lung Cancer Screening Programme.
Dr Chee said: “By working with Cheshire and Merseyside’s Lung Cancer Screening programme, we can use information from its participants to cross reference their blood samples and their outcome details to discover if we can target people who have early-stage lung cancer, or who may develop it. This study could be a gamechanger in cancer screening.”
Find more information about the trial here.
Sincerely,
Liverpool Noise
